Ontology highlight
ABSTRACT: Patient summary
We collected outcome data for major operations for prostate, bladder, and kidney cancers during the COVID-19 pandemic. These surgeries remain safe and training should be encouraged during the ongoing pandemic provided appropriate countermeasures are taken. Our real-life results are important for policy-makers and clinicians when counselling patients during the COVID-19 pandemic.
SUBMITTER: Tan WS
PROVIDER: S-EPMC7796655 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature

Tan Wei Shen WS Arianayagam Rajan R Khetrapal Pramit P Rowe Edward E Kearley Samantha S Mahrous Ahmed A Pal Raj R Fowler William W Heer Rakesh R Elajnaf Mohamed M Douglas-Moore Jayne J Leyshon Griffiths T R TR Voss James J Wilby Daniel D Al Kadhi Omar O Noel Jonathan J Vasdev Nikhil N McKay Alastair A Ahmad Imran I Abu-Nayla Islam I Lamb Benjamin B Hill George T GT Narahari Krishna K Kynaston Howard H Yousuf Arzu A Kusuma Venkata R M VRM Cresswell Jo J Cooke Pete P Chakravarti Aniruddha A Barod Ravi R Bex Axel A Kelly John D JD
European urology open science 20210109
COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed ...[more]